News Items

The Secret Global Court – Why Corporate Criminals and Corrupt Politicians Desperately Want the TPP

Obama needs to ensure he gets well compensated after leaving office for a job well done protecting, defending and further enriching the global oligarch class. This is precisely why he’s so adamant about passing the TPP during the upcoming lame duck session of Congress, when he knows “representatives” who no longer face reelection can be coerced or bribed into voting for this monumental public betrayal.

Rutgers Residence Hall Warns Students Against ‘Microassaults,’ ‘Microinsults’ & ‘Microinvalidations’

Just when you thought you had a handle on the treasonous thought-police infractions known as microagressions, folks at Rutgers University had to go ahead and further muddy the waters of what is and isn’t allowed to be uttered on today’s college campuses.
Since I know you’re all dying to find out, let’s turn to Campus Reform to learn about the latest verbal (and nonverbal) transgressions: “microassaults,” “microinsults’ & “microinvalidations”:

The FDA is Partly to Blame for Mylan’s EpiPen Price Gouging

The new head of the Food and Drug Administration (FDA) selected by President Barack Obama has very close ties to the pharmaceutical industry.
Dr. Robert Califf, an FDA deputy commissioner and cardiologist at Duke University, has had considerable dealings, including financial ones, with drug manufacturers, whose products must be approved by the agency he’s been tabbed to lead.

How the Chinese Government Muzzles Freedom of Expression in Canada

At least part of the message is beyond dispute: the cash flowing out of China into assets around the world has hit tsunami proportions, driven by fears of a slowing economy and a declining currency. Estimates peg the amount Chinese investors and companies moved out of the country last year at nearly $1 trillion, up more than sevenfold from 2014. Much of that money is being spent by Chinese companies looking to snap up Western assets, such as ChemChina’s US$43-billion bid to take over Swiss seed company Syngenta, or to pay down U.S. dollar-denominated debts.